Original Research
Published on 25 Jan 2022
Prediction of the Effects of Empagliflozin on Cardiovascular and Kidney Outcomes Based on Short-Term Changes in Multiple Risk Markers
- 5,925 views
- 11 citations
Original Research
Published on 25 Jan 2022
Original Research
Published on 25 Jan 2022
Original Research
Published on 25 Jan 2022
Correction
Published on 25 Jan 2022
Original Research
Published on 24 Jan 2022
Original Research
Published on 24 Jan 2022
Review
Published on 24 Jan 2022
Review
Published on 24 Jan 2022
Opinion
Published on 24 Jan 2022
Original Research
Published on 24 Jan 2022
Original Research
Published on 24 Jan 2022
Review
Published on 24 Jan 2022
Systematic Review
Published on 24 Jan 2022
Original Research
Published on 21 Jan 2022
Original Research
Published on 21 Jan 2022
Original Research
Published on 21 Jan 2022
Original Research
Published on 21 Jan 2022
Correction
Published on 21 Jan 2022
Review
Published on 21 Jan 2022
Review
Published on 21 Jan 2022
Original Research
Published on 21 Jan 2022
Systematic Review
Published on 21 Jan 2022
Original Research
Published on 21 Jan 2022
Original Research
Published on 21 Jan 2022